CROs Press for More Adaptive Trials and Predict Surge in Demand

Risk-averse sponsors are still slow to seek adaptive trial designs, but CROs building expertise in the field expect demand to increase.

http://www.outsourcing-pharma.com/Clinical-Development/CROs-Press-for-More-Adaptive-Trials-and-Predict-Surge-in-Demand?